Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Birchmeier, Walter Prof. Dr. (1) Lusatis, Simone (1) Mathas, Stephan Dr. (4) Schlag, Peter M. Prof. Dr. (24) Smith, Janice (1) Walther, Wolfgang Prof. Dr. (4) Wollert-Wulf, Brigitte (2) (-) Daniel, Peter Prof. Dr. (2) (-) Janz, Martin Dr. (4) (-) Stein, Ulrike Prof. Dr. (5) (-) Biologie maligner Lymphome (4) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Proteom Dynamik (2) (-) Translationale Onkologie solider Tumore (6) 1993 (1) 1994 (4) 1995 (1) 1996 (7) 1997 (7) 1998 (6) 1999 (4) 2000 (8) 2001 (3) 2002 (11) 2003 (7) 2004 (6) 2005 (8) (-) 2006 (10) 2007 (4) 2008 (6) 2010 (6) 2011 (9) 2013 (8) 2014 (3) 2016 (7) 2018 (3) 2019 (11) 2020 (15) 2021 (16) 2022 (19) 2023 (11) 2024 (4) 10 Ergebnisse: Active Filter: Daniel, Peter Prof. Dr.Janz, Martin Dr.Stein, Ulrike Prof. Dr.Biologie maligner LymphomeTranslationale Onkologie solider Tumore2006 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel 01. November 2006 / Gastroenterology The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor (TCF) signaling in colon cancer U. Stein F. Arlt W. Walther J. Smith T. Waldman E.D. Harris S.D. Mertins C.W. Heizmann D. Allard W. Birchmeier P.M. Schlag R.H. Shoemaker 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken 01. Januar 2006 "Multidrug-Resistenz". Zellulaere Transportprobleme und ihre Konsequenzen ["Multidrug resistance". Cellular transport problems and their consequences] U. Stein W. Walther P.M. Schlag 15. Juni 2006 / Hum Gene Ther Uptake, biodistribution, and time course of naked plasmid DNA trafficking after intratumoral in vivo jet injection W. Walther T. Minow R. Martin I. Fichtner P.M. Schlag U. Stein 15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas 10. Mai 2006 / BMC Cancer Genetic dissection of apoptosis and cell cycle control in response of colorectal cancer treated with preoperative radiochemotherapy I. Sturm B. Rau P.M. Schlag P. Wust B. Hildebrandt H. Riess S. Hauptmann B. Doerken P.T. Daniel 01. Januar 2006 Multidrug resistance U. Stein 01. September 2006 / Am J Cancer Reversal of ABC transporter-dependent multidrug resistance in cancer: A realistic option? U. Stein W. Walther
15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
01. November 2006 / Gastroenterology The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor (TCF) signaling in colon cancer U. Stein F. Arlt W. Walther J. Smith T. Waldman E.D. Harris S.D. Mertins C.W. Heizmann D. Allard W. Birchmeier P.M. Schlag R.H. Shoemaker
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
01. Januar 2006 "Multidrug-Resistenz". Zellulaere Transportprobleme und ihre Konsequenzen ["Multidrug resistance". Cellular transport problems and their consequences] U. Stein W. Walther P.M. Schlag
15. Juni 2006 / Hum Gene Ther Uptake, biodistribution, and time course of naked plasmid DNA trafficking after intratumoral in vivo jet injection W. Walther T. Minow R. Martin I. Fichtner P.M. Schlag U. Stein
15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
10. Mai 2006 / BMC Cancer Genetic dissection of apoptosis and cell cycle control in response of colorectal cancer treated with preoperative radiochemotherapy I. Sturm B. Rau P.M. Schlag P. Wust B. Hildebrandt H. Riess S. Hauptmann B. Doerken P.T. Daniel
01. September 2006 / Am J Cancer Reversal of ABC transporter-dependent multidrug resistance in cancer: A realistic option? U. Stein W. Walther